Verily Archives -

Koneksa aims to answer Parkinson’s-tracking challenge with AI

Phil Taylor digital, digital biomarker, digital health, Koneksa, neurology, Parkinson's disease, Verily, wearable 0 Comment

Healthcare technology firm Koneksa will carry out a study to evaluate whether digital biomarkers can be used to

Koneksa aims to answer Parkinson’s-tracking challenge with AI

https://pharmaphorum.com/news/koneksa-aims-to-answer-parkinsons-tracking-challenge-with-ai/

News/ News/ R&D

Verily taps Oncimmune tech for ‘long COVID’ study

Phil Taylor coronavirus, COVID-19, Long COVID, oncimmune, partnering, Verily 0 Comment

Alphabet’s Verily Life Science has contracted UK biotech Oncimmune to investigate autoantibodies in people who have developed long-lasting

Verily taps Oncimmune tech for ‘long COVID’ study

https://pharmaphorum.com/news/verily-taps-oncimmune-for-long-covid-study/

Digital/ News/ News

GSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapy

Phil Taylor bioelectronics, digital, digital health, Galvani Therapeutics, GlaxoSmithKline, Rheumatoid arthritis, Verily 0 Comment

The first patient has been treated with an implantable bioelectronic device developed by Galvani Therapeutics, set up by

GSK, Verily-backed Galvani starts trials of bioelectronic arthritis therapy

https://pharmaphorum.com/news/gsk-verily-backed-galvani-starts-trials-of-bioelectronic-arthritis-therapy/

Digital/ News/ News

Otsuka, Click trial digital depression therapy with Google

Richard Staines Click Therapeutics, depression, digital therapeutics, Otsuka, Verily 0 Comment

Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully

Otsuka, Click trial digital depression therapy with Google

https://pharmaphorum.com/news/otsuka-click-trial-digital-depression-therapy-with-google/

Digital/ News/ News

Google’s Verily eyes 2021 growth after $700m funding round

Dominic Tyer Alphabet, Google, health insurance, Onduo, Verily 0 Comment

Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors

Google’s Verily eyes 2021 growth after $700m funding round

https://pharmaphorum.com/news/google-verily-onduo-2021-growth-funding/

Digital/ News/ News

Verily plans digital ophthalmology joint venture with Santen

Richard Staines digital health, ophthalmology, santen, Verily 0 Comment

Verily is planning a digital ophthalmology joint venture with Japan’s specialist in the field, Santen. The joint venture

Verily plans digital ophthalmology joint venture with Santen

https://pharmaphorum.com/news/verily-plans-ophthalmology-joint-venture-with-santen/

Digital/ News/ News

Verily signs up four big pharmas to its clinical trials platform

Phil Taylor clinical research tools, clinical trials, Verily 0 Comment

Verily, the life sciences company owned by Google parent Alphabet, has teamed up with Novartis, Sanofi, Otsuka, and

Verily signs up four big pharmas to its clinical trials platform

https://pharmaphorum.com/news/verily-signs-up-four-big-pharmas-to-its-clinical-trials-platform/

Digital/ News/ News

Verily/Google use algorithm to detect diabetic eye disease

Richard Staines diabetic retinopathy, diabetica macular oedema, Google, ophthalmology, Verily 0 Comment

Verily and Google have developed a machine learning algorithm that can automatically detect diabetes-related eye disease, which could

Verily/Google use algorithm to detect diabetic eye disease

https://pharmaphorum.com/news/verily-google-use-algorithm-to-diabetic-eye-disease/

Digital/ News/ News

Verily builds US drug rehab campus amid opioid crisis

Richard Staines digital, opioids, Verily 0 Comment

Alphabet’s life sciences division Verily is building a rehab campus to help combat the opioid crisis, according to

Verily builds US drug rehab campus amid opioid crisis

https://pharmaphorum.com/news/verily-builds-us-drug-rehab-campus-amid-opioid-crisis/

Trending

Verily

Login